Kemnay Advisory Services’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83K Buy
248
+27
+12% +$8.55K 0.01% 191
2026
Q1
$71.2K Buy
221
+160
+262% +$49.5K 0.01% 183
2025
Q4
$18K Buy
+61
New +$11.4K ﹤0.01% 579

Other funds holding PRAX

Kemnay Advisory Services's PRAX Position: Q2 2026 in Review

Kemnay Advisory Services increased its Praxis Precision Medicines (PRAX) stake by 12% in Q2 2026, buying an estimated $8.55K and bringing the position to 248 shares worth $83K. The position accounts for 0.01% of the portfolio, ranked #191.

Kemnay Advisory Services first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Kemnay Advisory Services held 248 shares of Praxis Precision Medicines worth $83K as of Q2 2026.
  • Kemnay Advisory Services bought 27 Praxis Precision Medicines shares in Q2 2026, an estimated $8.55K.
  • Praxis Precision Medicines made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #191 holding.
  • Kemnay Advisory Services first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.